Byron Austin leads corporate responsibility at Organon, a new pharma company focused on the health of women. He is also responsible for managing how the company engages its relevant stakeholders on a variety of Environmental, Social, and Governance (ESG) issues. Prior to Organon, Byron led ESG communications at Teva Pharmaceuticals, where he also had responsibility for the company’s corporate social responsibility efforts in the United States and Canada while supporting the company’s global health and access strategy around the world. Before joining Teva, Byron led the healthcare practice at Business for Social Responsibility (BSR), a global business network and consultancy focused on building the capacity of large companies to become more sustainable and socially responsible. At BSR, he advised over 25 companies in the biopharmaceutical and medical device industry on their ESG and sustainability strategies. Prior to BSR, Byron managed and developed global health partnerships at Johnson & Johnson, where he engaged a variety of stakeholders in the fields of NCDs, HIV/AIDS, maternal and child health, and digital health. Byron began his career in global health at an HIV/AIDS NGO based in South Africa called mothers2mothers International and later served as a management consultant at Rabin Martin in New York City.
Speaking In
3:00 PM - 3:45 PM (EST)
Monday, February 6
With more than $500 billion flowing into ESG-focused funds over the past year, this fastest growing…
South Broadway Ballroom